Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Make or break for Biomed here. Last chance not to be labeled classic front load pump and dump machine. One more chance here but if selloff continues no other way to call it. Seen this with them countless times..
Isn't the CEO a career penny stock CEO. Has he not been involved with other pennies. Wake up folks. No promised land coming here.....only pain.
Those are the last famous words echoed on the boards of many stinky pinkies
vintage move...like the old audited financials are coming....but...sorry they'll be a bit delayed....
no........the countdown timer did the trick....it reeked of penny scam.
good point...imagine them trying to navigate the path to FDA approval...what a joke....trying to rescue the data.....gotta laugh...they couldn't come up with something better. I am sure more PR will be coming as the countdown clock didn't elevate the price enough to line the pockets...so the games will continue for awhile.
There are no life lessons to be learned from investing in pinksheets. This is the bottom of the barrel where the more experienced prey on the desperate looking to get rich quick. There is one investing lesson.....most will lose their shirt in pinky plays....especially those so blinded by the pursuit of cash that they can't see clearly.
I've seen EPWN, SLJB, Cyberkey and others........they all had many hubbers fooled too.
I am also certain some of the staunch supporters are spending some time this weekend weaving the next chapter for Monday posts...hoping to stem the bleeding as they exit. Do not be surprised one day to see folks have jumped ship at your expense. It's happened before. Be careful.
Vintage scam....like sulja. watch and learn as deadlines are continually set and missed. with each new deadline set more bagholders buy in until the implosion...
In today's age nobody loses all the data. No legit web building company would handle data that is not securely backed up or preserved should a problem arise. This reeks of scam. Another telltale pinky scam sign is when folks refer to the CEO by first name as if they have a personal relationship.
Let's get real though.....this smells of a penny scam....seen it before and will again....failure to deliver....lots that looks promising but nothing truly ever gets delivered
we have heard that line from countless other pinky CEOs who are wearing stripes
rescue the data....are you for real....no backup data.......
I have seen this story many times in pinkyland land. shattered hopes and dreams...blind believers when the signs are there....
you have got to be kidding....a tech company whose servers are situated at risk from heavy rainfall....
who the heck was foolish enough to expect the unveiling of the next great medical device when the curtain was lifted...
every email from the supposed CEO proclaims great things in store....the old dangling carrot....another pinky classic trick
Oh yes....the adventure continues....why do these things always happen in pinkyland. ...........
Is the website in question really a product of the company or is this some type of scam....
This is vintage classic pinky stalling and stringing along bagholders to be....IMO
Well those who wanted in under 3 cents will have a chance Monday.
So you holders are supposed to believe a company that specializes in getting websites up has it's servers in an area of the building that could possibly be threatened by bad weather. This may yet join the ranks of SLJB, EPWN and others..
Accumulating funds to buy in the 10-15 cent range for the FDA approval. Signs were there that year end was not going to happen. Enormous profits were not enough for some as greed once again ruled and fueled a collapse and broken dreams.
From another board.
Huge news - CEL-2000 worked better than Enbrel in treating rheumatoid arthritis, news out only in Medical Journal so far...........
Int Immunopharmacol. 2010 Jan 11. [Epub ahead of print]
CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine / Chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
Zimmerman DH, Taylor P, Bendele A, Carambula R, Duzant Y, Lowe V, O'Neill SP, Talor E, Rosenthal KS.
Research and Development, CEL-SCI Corporation, 8229 Suite 802 Vienna, VA 22182.
The mouse model of collagen induced arthritis (CIA) effectively mimics human disease and thus is useful for testing and development of rheumatoid arthritis (RA) therapies. We developed a Ligand Epitope Antigen Presentation System (L.E.A.P.S.) peptide hetero-conjugate vaccine containing an epitope of human Collagen type II (CEL-2000) that acted as a therapeutic vaccine in the collagen induced arthritis (CIA) mouse model. L.E.A.P.S. technology converts a small peptide containing a disease specific epitope into an immunogen by attaching it to an immune or T cell binding peptide (I/TCBL). For CEL-2000, a peptide from human collagen Type II (254-273) is attached to the I/TCBL peptide from human beta2 microglobulin (J). Treatment with CEL-2000 limited disease (CIA) progression, as demonstrated by reduced Arthritic Index (AI) score, and footpad swelling. Efficacy was confirmed by histopathological microscopic examination of tissues at the end of the study. CEL-2000 limited disease progression as well or better than the etanercept (Enbrel) therapeutic control with significantly better histopathological results than the etanercept treated mice. Most interestingly, CEL-2000 therapy modulated serum cytokine levels with an increase in IL-12p70 and IL-10, which are not seen with etanercept therapy, and reduced IL-17 and TNF-alpha, also seen with etanercept, among other cytokines studied. CEL-2000 was safe and well tolerated for the mice that received 5 injections given every two weeks in a 90day study supporting its potential usage for long term therapy. These studies demonstrate that fewer treatments with CEL-2000 provide therapy at least as effective as etanercept by specifically modulating the disease producing autoimmune response.
http://www.ncbi.nlm.nih.gov/sites/entrez
Huge news - CEL-2000 worked better than Enbrel in treating rheumatoid arthritis, news out only in Medical Journal so far...........
Int Immunopharmacol. 2010 Jan 11. [Epub ahead of print]
CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine / Chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
Zimmerman DH, Taylor P, Bendele A, Carambula R, Duzant Y, Lowe V, O'Neill SP, Talor E, Rosenthal KS.
Research and Development, CEL-SCI Corporation, 8229 Suite 802 Vienna, VA 22182.
The mouse model of collagen induced arthritis (CIA) effectively mimics human disease and thus is useful for testing and development of rheumatoid arthritis (RA) therapies. We developed a Ligand Epitope Antigen Presentation System (L.E.A.P.S.) peptide hetero-conjugate vaccine containing an epitope of human Collagen type II (CEL-2000) that acted as a therapeutic vaccine in the collagen induced arthritis (CIA) mouse model. L.E.A.P.S. technology converts a small peptide containing a disease specific epitope into an immunogen by attaching it to an immune or T cell binding peptide (I/TCBL). For CEL-2000, a peptide from human collagen Type II (254-273) is attached to the I/TCBL peptide from human beta2 microglobulin (J). Treatment with CEL-2000 limited disease (CIA) progression, as demonstrated by reduced Arthritic Index (AI) score, and footpad swelling. Efficacy was confirmed by histopathological microscopic examination of tissues at the end of the study. CEL-2000 limited disease progression as well or better than the etanercept (Enbrel) therapeutic control with significantly better histopathological results than the etanercept treated mice. Most interestingly, CEL-2000 therapy modulated serum cytokine levels with an increase in IL-12p70 and IL-10, which are not seen with etanercept therapy, and reduced IL-17 and TNF-alpha, also seen with etanercept, among other cytokines studied. CEL-2000 was safe and well tolerated for the mice that received 5 injections given every two weeks in a 90day study supporting its potential usage for long term therapy. These studies demonstrate that fewer treatments with CEL-2000 provide therapy at least as effective as etanercept by specifically modulating the disease producing autoimmune response.
http://www.ncbi.nlm.nih.gov/sites/entrez
I had a lenghthy email written on this fiasco and then decided it's a waste of energy to recite the obvious.....this is plain and simple a joke....no more or less needed. Please folks do not be naive here.......
For a supposed no brainer blockbuster approval the training is terrible. The approval can also come early here so this is not the sign you'd like to see.
I've been holding shares of GNVC since .76 cents. What is the signficance of March if the next results are due soon. I 've seen io io mention this in several places. thanks
Oh well.....think some of us have been shouting this for months. Lessons learned for FDA novices...
Today's news -
Who is the major cancer center?
What publication was this revelation published in?
This is the biggest crock of $F%%$% I've ever seen.
This unfortunately is one of those come back in a year.
This one is eerily similar to other busts...........great hopes and dreams....but two years out still no movement and a cheerleading squad hanging around and keeping the faith. Come on....this is headed no where with this action......If this was such a great opportunity don't you think trading would be a bit different. This is called a reach..........
Most legit companies in lab/pharma/diagnostics list their management team and bios on the site. There is nothing but an advisory board comprised of someone from Sophora lab they partnered with, also the only lab supposedly using this great equipment, and a skin doctor from Florida..
LOL...get real the 200 scanner looks like a glorified microscope with an outdated PC....there is so much advance tech in lab & diagnostics........check out what pathologists work with today and then judge whether that clip art is a technological breakthrough.
Added here.......closing in on 500k.
What the heck...what's another year delay for approval.
CHEAP SHARES COMING THIS AM...
Compare the Chromocure and Sophoro websites to any other clin lab or diagnostics manufacturer and then make a decision on whether this is smoke and mirrors.
May still take a chance and buy in the .30s early today